FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116765675> ?p ?o ?g. }

• W2116765675 endingPage "1227" @default.
• W2116765675 startingPage "1224" @default.
• W2116765675 abstract "Background: The most frequently administered treatment for asymptomatic ISHLT Grade 3A cardiac allograft rejection is intravenous steroids or oral steroid pulse with a taper. This study analyzes the efficacy of 3-day 100-mg course of prednisone without a tapered regimen for the treatment of asymptomatic moderate cardiac allograft rejection. Methods All new episodes of asymptomatic ISHLT Grade 3A rejections were treated with oral steroid pulse without taper, consisting of 100 mg of prednisone for 3 consecutive days followed by resuming the pre-rejection steroid dose on the fourth day. We retrospectively reviewed the histologic response of all treated episodes among all cardiac transplant recipients transplanted between January 1995 through December 1997 who were treated with triple therapy consisting of cyclosporine, azathioprine and steroids. Patients receiving additional or alternative immunosuppressives were excluded from the study. The treated episodes were analyzed as responders if the follow-up biopsy were Grade 0, 1A, 1B, or 2; treatment was counted as non-responders if the follow-up biopsy showed Grade 3A or higher. Results Of 230 cardiac transplant recipients, 100 patients received a 3-day 100 mg course of prednisone without taper for 174 new episodes of asymptomatic ISHLT Grade 3A rejection. The overall response rate was 75% (130/174 rejection episodes). A significant difference in the response rate was observed depending on the number of days post transplant. A comparison of the success rates among rejections which occurred > 90 days post transplant versus < 30 days revealed responses to be 88% versus 70% (p = 0.02); for rejections treated > 60 days post transplant versus < 30 days showed success rates of 84% versus 70% (p = 0.04). The mean age of the recipient revealed a trend to be lower among the non-responder group (49 ± 12 years versus 53 ± 9 years, p = 0.07). Having left ventricular assist device as a bridge to transplant did not significantly affect the treatment outcome. The response rates were 69% for the patients who required the assist device versus 77% for those not bridged (p = ns). There was no significant difference in the gender or the baseline immunosuppressive doses between the responders and non-responders. The cost of a 3-day outpatient, visiting nurse supervised intravenous steroid therapy versus 3 days of oral prednisone was $861 vs $6.88. Conclusion Oral steroid pulse without taper is an effective and economical way to treat asymptomatic moderate grade cardiac allograft rejection. A 3-day course of 100 mg of prednisone without taper should be considered as first line of therapy for clinically stable form of moderate cardiac allograft rejection occurring > 60 days post transplant." @default.
• W2116765675 created "2016-06-24" @default.
• W2116765675 creator A5006688566 @default.
• W2116765675 creator A5024493005 @default.
• W2116765675 creator A5039589228 @default.
• W2116765675 creator A5061706688 @default.
• W2116765675 creator A5065472530 @default.
• W2116765675 creator A5087034704 @default.
• W2116765675 creator A5087973499 @default.
• W2116765675 date "1999-12-01" @default.
• W2116765675 modified "2023-09-30" @default.
• W2116765675 title "Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection" @default.
• W2116765675 cites W1993356417 @default.
• W2116765675 cites W2017894748 @default.
• W2116765675 cites W2024951818 @default.
• W2116765675 cites W2052085452 @default.
• W2116765675 cites W2053037626 @default.
• W2116765675 cites W2776961186 @default.
• W2116765675 doi "https://doi.org/10.1016/s1053-2498(99)00098-4" @default.
• W2116765675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10612382" @default.
• W2116765675 hasPublicationYear "1999" @default.
• W2116765675 type Work @default.
• W2116765675 sameAs 2116765675 @default.
• W2116765675 citedByCount "22" @default.
• W2116765675 countsByYear W21167656752012 @default.
• W2116765675 countsByYear W21167656752013 @default.
• W2116765675 countsByYear W21167656752014 @default.
• W2116765675 countsByYear W21167656752015 @default.
• W2116765675 countsByYear W21167656752016 @default.
• W2116765675 countsByYear W21167656752017 @default.
• W2116765675 countsByYear W21167656752019 @default.
• W2116765675 countsByYear W21167656752020 @default.
• W2116765675 countsByYear W21167656752022 @default.
• W2116765675 countsByYear W21167656752023 @default.
• W2116765675 crossrefType "journal-article" @default.
• W2116765675 hasAuthorship W2116765675A5006688566 @default.
• W2116765675 hasAuthorship W2116765675A5024493005 @default.
• W2116765675 hasAuthorship W2116765675A5039589228 @default.
• W2116765675 hasAuthorship W2116765675A5061706688 @default.
• W2116765675 hasAuthorship W2116765675A5065472530 @default.
• W2116765675 hasAuthorship W2116765675A5087034704 @default.
• W2116765675 hasAuthorship W2116765675A5087973499 @default.
• W2116765675 hasConcept C126322002 @default.
• W2116765675 hasConcept C141071460 @default.
• W2116765675 hasConcept C2775934546 @default.
• W2116765675 hasConcept C2776760755 @default.
• W2116765675 hasConcept C2776804153 @default.
• W2116765675 hasConcept C2777910003 @default.
• W2116765675 hasConcept C2778720950 @default.
• W2116765675 hasConcept C2779134260 @default.
• W2116765675 hasConcept C2781413609 @default.
• W2116765675 hasConcept C71924100 @default.
• W2116765675 hasConcept C90924648 @default.
• W2116765675 hasConceptScore W2116765675C126322002 @default.
• W2116765675 hasConceptScore W2116765675C141071460 @default.
• W2116765675 hasConceptScore W2116765675C2775934546 @default.
• W2116765675 hasConceptScore W2116765675C2776760755 @default.
• W2116765675 hasConceptScore W2116765675C2776804153 @default.
• W2116765675 hasConceptScore W2116765675C2777910003 @default.
• W2116765675 hasConceptScore W2116765675C2778720950 @default.
• W2116765675 hasConceptScore W2116765675C2779134260 @default.
• W2116765675 hasConceptScore W2116765675C2781413609 @default.
• W2116765675 hasConceptScore W2116765675C71924100 @default.
• W2116765675 hasConceptScore W2116765675C90924648 @default.
• W2116765675 hasIssue "12" @default.
• W2116765675 hasLocation W21167656751 @default.
• W2116765675 hasLocation W21167656752 @default.
• W2116765675 hasOpenAccess W2116765675 @default.
• W2116765675 hasPrimaryLocation W21167656751 @default.
• W2116765675 hasRelatedWork W1898998924 @default.
• W2116765675 hasRelatedWork W1965694031 @default.
• W2116765675 hasRelatedWork W1989553462 @default.
• W2116765675 hasRelatedWork W2002870312 @default.
• W2116765675 hasRelatedWork W2037116344 @default.
• W2116765675 hasRelatedWork W2116765675 @default.
• W2116765675 hasRelatedWork W2356066682 @default.
• W2116765675 hasRelatedWork W2411194530 @default.
• W2116765675 hasRelatedWork W4237973243 @default.
• W2116765675 hasRelatedWork W4302062179 @default.
• W2116765675 hasVolume "18" @default.
• W2116765675 isParatext "false" @default.
• W2116765675 isRetracted "false" @default.
• W2116765675 magId "2116765675" @default.
• W2116765675 workType "article" @default.